We've already tacked three decades onto the average lifespan of an American, so what's wrong with adding another few decades?
A centenarian riding his bike in Long Beach, California (Reuters).
So far as we know, the last hundred years have been the most radical period of life extension in all of human history. At the turn of the twentieth century, life expectancy for Americans was just over 49 years; by 2010, that number had risen to 78.5 years, mostly on account of improved sanitation and basic medicine. But life extension doesn't always increase our well-being, especially when all that's being extended is decrepitude. There's a reason that Ponce de Leon went searching for the fountain of youth---if it were the fountain of prolonged dementia and arthritis he may not have bothered.
Over the past twenty years, biologists have begun to set their sights on the aging process itself, in part by paying close attention to species like the American Lobster, which, despite living as long as fifty years, doesn't seem to age much at all. Though some of this research has shown promise, it's not as though we're on the brink of developing a magical youth potion. Because aging is so biologically complex, encompassing hundreds of different processes, it's unlikely that any one technique will add decades of youth to our lives. Rather, the best we can hope for is a slow, incremental lengthening of our "youth-span," the alert and active period of our lives.
Not everyone is thrilled by the prospect of radical life extension. As funding for anti-aging research has exploded, bioethicists have expressed alarm, reasoning that extreme longevity could have disastrous social effects. Some argue that longer life spans will mean stiffer competition for resources, or a wider gap between rich and poor. Others insist that the aging process is important because it gives death a kind of time release effect, which eases us into accepting it. These concerns are well founded. Life spans of several hundred years are bound to be socially disruptive in one way or another; if we're headed in that direction, it's best to start teasing out the difficulties now.
But there is another, deeper argument against life extension---the argument from evolution. Its proponents suggest that we ought to avoid tinkering with any human trait borne of natural selection. Doing so, they argue, could have unforeseen consequences, especially given that natural selection has such a sterling engineering track record. If our bodies grow old and die, the thinking goes, then there must be a good reason, even if we don't understand it yet. Nonsense, says Bennett Foddy, a philosopher (and flash game developer!) from Oxford, who has written extensively about the ethics of life extension. "We think about aging as being a natural human trait, and it is natural, but it's not something that was selected for because it was beneficial to us." Foddy told me. "There is this misconception that everything evolution provides is beneficial to individuals and that's not correct."
Foddy has thought long and hard about the various objections to life extension and, for the most part, has found them wanting. This is our conversation about those objections, and about the exciting new biology of aging.
People usually regard life extension as a futuristic technology, but you begin your paper by discussing the ways that we've already extended the human lifespan. What's driven that?
Foddy: The reason I present it that way, is that there's always this background moral objection in enhancement debates, where a technology is perceived to be new, and by virtue of being new, is depicted as threatening or even strange. That goes for everything from genetic engineering to steroids to cloning and on and on. I think it's always worth contextualizing these things in terms of the normal. So with human cloning it's worth remembering that it's exactly the same as twinning. With steroids, it's worth remembering that in many ways it's not that different from training and exercise, and also that people have been taking testosterone since ancient times. I think this way you can kind of resist the idea that something is wrong just because it's strange.
When you're talking about medicines that help us live longer, it's important to realize how much we've already accomplished. In the last 150 years or so, we've doubled our life span from 40 to 80 years, and that's primarily through the use of things you can characterize as being medical science. In some cases it's clear that we're talking about medical enhancement---vaccines, for instance, or surgical hygiene and sterilization. And then more broadly there are other, non-medical things like the sanitation of the water supply and the pasteurization of milk and cheese. All of these things have saved an enormous amount of life.
It used to be that people would die of an infectious disease; they'd be struck down when they were very young or when they were older and their immune system was weak. Now almost nobody in the first world dies of infectious disease; we've basically managed to completely eradicate infectious disease through medical science. If, at the outset of this process, you asked people if we should develop technologies that would make us live until we're 80 on average instead of until we're 40, people might have expressed these same kind of misgivings that you hear today. They might have said, "Oh no that would be way too long, that would be unnatural, let's not do that."
So, in a way, we shouldn't view it as being extremely strange to develop these medicines, but in another sense we're at a new stage now, because now we're at the forefront of having medicines that actually address the aging process. And that's what I'm interested in talking about---the kinds of medicines that actually slow down the aging process, or at least some of the mechanisms of aging.
Can you explain how senescence, the biological process of aging, is unevenly distributed across species?
Foddy: There are different animals that are affected differently by various processes of aging. In my paper I go into the case of the American Lobster, which lives about as long as a human being. When you dissect one of these lobsters at the end of its life, its body doesn't show much in the way of weakening or wasting like you see in a human body of advanced age. That suggests that aging can evolve differently in different species. Lobsters seem to have evolved an adaptation against the cellular lifespan. There's this phenomenon where the DNA in our cells basically unravel after they've divided a certain amount of times, but lobsters have this enzyme that helps them replenish their telomeres---the caps that hold DNA together.
That's one of the reasons why lobsters don't seem to undergo aging in the same way that we do. Other species give off an antioxidant chemical in their bodies that prevent these oxidizing free radicals in our bodies from breaking us down. That's why doctor's recommend that you have a certain amount of antioxidants---some species are really good at producing those naturally.
There is this idea that when you're evolving you make certain trade-offs. Lobsters and clams don't really move around a lot; their bodies move and grow very slowly and one of the upsides of that is that they've been able to invest their evolutionary chips, so to speak, in resisting the aging process. Human beings, on the other hand, have to move around quite a lot. We have giant brains and we have to be able to run away from saber tooth tigers. As a result we have bodies that burn a lot of calories, and so that's where our chips are invested. It's just a difference in our evolutionary environment and that's why we've evolved to live and die the way we do. But it could have easily not turned out that way---that's the point I really want to make.
What are the current biological limits on our human life span, or our human "youth span," as you call it---the time that we're able to live as young, vibrant, reproducing individuals?
Foddy: The sky is sort of the limit there. There won't be a magic pill that gives us infinite youth, but over time there will probably be different technologies that allow you a few extra years of youth. We think of aging as being a unitary thing, but it's made up of hundreds of different processes. So, one of the different things we think about, for example, is dementia, the state where your brain sort of wastes away. Now, if we discover a way of reversing that process, or slowing that process, that would be one dimension where we no longer age, where our minds will stay youthful for longer. It's also possible that we might be able to find a way of stopping people's muscles from wasting away as they get older.
Nothing is going to be super dramatic, but there will be a point where you'll look back a hundred years and notice that people used to get really kind of feeble and after awhile they weren't capable of really thinking or processing information anymore, and they had to go into a home and they had to be looked after and nursed for a time. And that will seem very old-fashioned and very barbaric, but I very much doubt it will happen at a moment in time where we suddenly realize that some magic pill has exponentially extended our youth. Part of that's because we're not exactly clear what aging is. We've identified a whole range of processes, but there ere still a whole lot of arguments in the scientific community about what is really responsible for aging, and which of the processes are subsidiary to other processes.
Have we glimpsed, even theoretically, ways that we might add to that youth-span. What are the bleeding edge technologies that might allow us to overcome aging?
Foddy: I'm not a scientist, so I don't want to weigh in too heavily on somebody's body of research. We've seen promising results looking at the lobsters and we've seen promising results with antioxidants, even aspirin, but as I said these things are going to be incremental. You meet a lot of people in the scientific community that are true believers and they're expecting a kind of a radical thing. And it's not as though we never have a radical thing in medicine, but what we have more frequently is incremental advances.
Cancer is a great example of the kind of incremental progress I'm talking about. In 1970, your odds of surviving 5 years after you've were diagnosed with certain kinds of cancer were slim; those chances have increased substantially. But we still react to the idea of getting cancer as though it were 1970 because we don't really process incremental changes. Like with chemotherapy, they just change out one or two drugs every year based on trials that show that the new drug is 2 percent more effective than the previous drug. That's constantly going on, but it really isn't announced. Instead, we get the occasional story in the news about a miracle cure for cancer, and it always turns out not to be as good as they had hoped and everyone begins to get disillusioned about science and the value of medical progress. But when you run the comparisons across decades, you see something much more dramatic.
You give an interesting account of how the aging process evolved in humans. You argue that aging is not the result of an optimizing process, but that instead it's a byproduct of an optimizing process. Can you explain why that difference is so important?
Foddy: I should say, first of all, that this is not original to me; this is very well established in evolutionary biology. We have a number of genetic traits that we developed because they were advantageous from the perspective of natural selection---that is, they helped us to survive and reproduce. People that had the gene for that trait had the ability to reproduce more than people that didn't have it. It's easy to imagine that every gene that we have is selected because it gave a positive advantage in this way, but it turns out there are trade-offs. A number of the processes of aging seem to have arisen because our bodies were not doing enough maintenance, because they were busy doing something else. The misconception that people often have is that any trade-off that we have is going to be directly beneficial, directly advantageous. But that's not right.
The second thing to say is that aging usually happens to an organism after it reaches menopause. Things that happen after menopause are much less interesting in terms of evolution, because they have much less of an effect. If I've already reached the age where I can't reproduce, then aging that takes effect at this point in my life is not going to affect whether or not I reproduce. The game is sort of already over for me. As a result, natural selection doesn't tend to weed out genes that take effect after you've reached the age of menopause. So, there is this idea that over time you can amass genes in your genome that have nothing to do with survival or not surviving, because they only activate after you reach a certain age. So, over time, some of these are going to be good genes and some of them are going to be bad. It's going to be this kind of mix, but it's certainly not going to be the case that they're on balance beneficial. We've got hundreds or thousands of genes that don't start to harm us until we reach old age, and those genes are responsible for a lot of what actually constitutes aging. So, in this sense, we think about aging as being a natural human activity or a human trait---and it is natural, but it's not something that was selected because it was beneficial to us. There is this misconception that everything evolution provides has to be beneficial to individuals and that's not correct.
One defense of aging that your paper takes quite seriously is the argument from evolution, which was first put forth by Frances Fukuyama. Fukuyama claims that we should resist the temptation to tinker with any characteristic that we have been given through the process of natural selection. He argues that evolution can be relied upon to produce good results and that we ought not to mess with the fruit of its processes. What's wrong with this view?
Foddy: Fukuyama has this idea that evolution is very complicated, which is true. We don't always understand why we've evolved to be a certain way. Sometimes it looks like something is useful, but in fact it's performing some kind of role that we don't know much about. Fukuyama is also correct that sometimes we interfere with complicated biological systems without really understanding what the effects will be, and that then we wind up with some unwanted effect. That's all true.
The thing that I disagree with him about is his presumption that if we have a trait that's evolved, that it must be beneficial to us in some way, and that we have some good reason for allowing that trait stick around. Now he's not talking strictly about aging; his book discusses all kinds of intervention on the human organism. But, when it comes to aging, his argument can't even succeed on its own merits, because we know for a fact that aging is not the sort of thing that is produced by natural selection in the kind of positive way that he is talking about. He says it's not always easy to do nature one better, but that's not what we're doing when we're combating aging. We're not trying to do nature one better, because nature doesn't care that we grow old and die. This is neglect, evolutionary neglect. We shouldn't think about it as interfering with the sort of complex ecological balance in the way that he's worried about.
Now that's not to say that our current mode of life extension is ideal. Some of the biggest strains on our resources stem from the fact that populations are getting older as birthrate's go down, especially in the first world. Aging societies are spending more and more on nursing, and so I think that it makes sense to pursue a youth-extending medicine that would diminish the number of years that we have to spend in nursing homes. You could imagine us living more like the lobster, where we still live to be about 80-85, but we're alert and active until we drop dead. In that scenario we wouldn't have this giant burden where the state has to support and pay to nurse people that are unable to look after themselves anymore.
Now, it has to be said that the story of medicine and medical progress in the past 50 years has not been heading that way. If anything, we're extending the number of years that we spend needing nursing. We've gotten good at keeping people alive once they're fairly decrepit. And that sort of guarantees that you have the maximum drain on resources, while also producing the kind of minimum amount of human benefit. You get to be 90 years old and your hip goes out, and we give you a massively expensive hip replacement, but we don't do things to prevent your body from wasting away and becoming corroded when you're 20, 30 or 40.
There's this great Greek myth, the myth of Tithonus, that always comes to mind. Tithonus was a mortal who was in love with Eos, the goddess of the dawn. Eos didn't want Tithonus to grow old and die, so she went to Zeus to ask for eternal life, which was granted. But, she forgot to ask for eternal youth, and so Tithonus just gets older and older and more decrepit, and eventually he can't really move, and then finally he turns into a grasshopper in the end. That's sort of the course that we're on with our current approach to medicine and life extension.
Some ethicists have pointed out that death is one of the major forces for equality in the world, and that welfare disparities will be worsened if some people can afford to postpone old age, or avoid it altogether, while others are unable to. What do you say to them?
Foddy: I think that's right. I mean there are concerns whenever we develop any kind of medicine or any kind of technology---the concern that these things are going to widen welfare gaps. The story of industrialization is that the people who could afford the cars and machines and factories in Western countries were able to produce a lot more and generate a lot more wealth than people in poorer agrarian economies. That's a serious issue. It's probably true that if people in the first world were, through some sort of medical intervention, able to live to be 200 years old and people in Bangladesh were still dying at a relatively young age, that would tend to widen the distance in personal wealth.
And look this has already happened. It's already unfair that I will on average live to be 80 and yet, if I were born before some arbitrary date, or in some other place, I would live much less longer. Those things are unfair and it's worth worrying about them, but I don't think the correct response is to hold off on the science. It's better if everybody can eventually get this medicine, because living a long time is not a positional good, it's an absolute good. It would be great if everybody could live to be 150, because that would benefit every single person. It's not a good that benefits you only if other people are worse off. When you have goods like that you should try to develop them and then you should worry separately about making sure that they get delivered to people in poorer areas, whether it's through government aid or massive production.
Another objection to the elimination of aging is this idea that the aging process makes an elderly person's death less painful for the survivors around her, because it gradually forces people to stop relying on her, and forces her to gradually remove herself from society. You call this the argument from psycho-social history.
Foddy: This is Leon Kass' argument. He thinks aging is just fantastic for this reason because it helps us to let go of somebody. And of course it's true that when people grow old, they become less useful to society, and more socially difficult, which places burdens on people. And in a lot of cases we respond to this by cutting them out of our lives, essentially. People get older, they move into a nursing home, and we see them less and less, and then when they finally die everyone's like, "well it was expected." Advanced age sort of helps us prepare emotionally for letting go of people, but it seems to me that it's not good for the person who gets old.
Now, what would the world be like if people dropped dead in good health when they reach a certain age? It would be very sad, but on the upside the person would've had 20 or 30 years of additional integration into society and we would've been able to spend more time with them. I've got to say that I would've enjoyed my grandmother's presence a lot more if she'd been able to run around and to play and work and be part of society in her extremely advanced age.
Nick Bostrom has said that people have fallen victim to a kind of Stockholm syndrome when it comes to aging. The idea being that because aging has always been an insurmountable obstacle for humanity, that we have dignified it more than it deserves, that we contort ourselves logically and rhetorically to defend it precisely because it is so inescapable. Does that sound right to you?
Foddy: Yes, I think that's right, although Nick draws conclusions that are a bit more extreme than I would tend to draw. I think that we do have a tendency to kind of rationalize things that we don't think we can do anything about. This is a perfectly healthy attitude if you really can't do anything about the aging process---it's better to accept it and kind of talk about it as being a natural part of life, not something to rail against or feel bad about. It's something that everybody goes through. Now if it did so happen that we could discover a medicine that completely prevents that process from taking place, we would have to re-evaluate at that stage and realize that we've done some emotional rationalization here and the conditions for it no longer apply. We no longer need to comfort ourselves with the inevitability of death if it's not actually inevitable.
Having said that, death is, in fact, inevitable. Even if we solve every medical problem, you still have a 1 in 1,000 chance of dying every year by some sort of accident. So, on those odds you could probably expect to live to be about 1,000. I don't think it's ever going to be the case that we will live forever. It's not even going to be 1,000. We're probably talking about living to be 120 or 150 or somewhere around there, but to me the idea that we have to accept living to 80 rather than 120 is bizarre given that it's not so long ago that we lived to 40.
A British broadcaster doggedly tried to put words into the academic’s mouth.
My first introduction to Jordan B. Peterson, a University of Toronto clinical psychologist, came by way of an interview that began trending on social media last week. Peterson was pressed by the British journalist Cathy Newman to explain several of his controversial views. But what struck me, far more than any position he took, was the method his interviewer employed. It was the most prominent, striking example I’ve seen yet of an unfortunate trend in modern communication.
First, a person says something. Then, another person restates what they purportedly said so as to make it seem as if their view is as offensive, hostile, or absurd.
Twitter, Facebook, Tumblr, and various Fox News hosts all feature and reward this rhetorical technique. And the Peterson interview has so many moments of this kind that each successive example calls attention to itself until the attentive viewer can’t help but wonder what drives the interviewer to keep inflating the nature of Peterson’s claims, instead of addressing what he actually said.
All parents remember the moment when they first held their children—the tiny crumpled face, an entire new person, emerging from the hospital blanket. I extended my hands and took my daughter in my arms. I was so overwhelmed that I could hardly think.
Afterward I wandered outside so that mother and child could rest. It was three in the morning, late February in New England. There was ice on the sidewalk and a cold drizzle in the air. As I stepped from the curb, a thought popped into my head: When my daughter is my age, almost 10 billion people will be walking the Earth. I stopped midstride. I thought, How is that going to work?
Corporate goliaths are taking over the U.S. economy. Yet small breweries are thriving. Why?
The monopolies are coming. In almost every economic sector, including television, books, music, groceries, pharmacies, and advertising, a handful of companies control a prodigious share of the market.
The beer industry has been one of the worst offenders. The refreshing simplicity of Blue Moon, the vanilla smoothness of Boddingtons, the classic brightness of a Pilsner Urquell, and the bourbon-barrel stouts of Goose Island—all are owned by two companies: Anheuser-Busch InBev and MillerCoors. As recently as 2012, this duopoly controlled nearly 90 percent of beer production.
This sort of industry consolidation troubles economists. Research has found that the existence of corporate behemoths stamps out innovation and hurts workers. Indeed, between 2002 and 2007, employment at breweries actually declined in the midst of an economic expansion.
“Consumers are jaded about advertising in a way they weren’t several decades ago.”
MasterCard unveiled its new logo earlier this summer, and as far as rebrandings go, the tweaks were subtle: The company kept its overlapping red and yellow balls intact, and moved its name, which was previously front and center, to beneath the balls, while making the text lowercase. With increasing frequency, MasterCard said, it would do away with using its name in the logo entirely. The focus would be more on the symbol than the words.
MasterCard’s move reflects a wider shift among some of the most widely recognized global brands to de-emphasize the text in their logos, or remove it altogether. Nike was among the first brands to do this, in 1995, when its swoosh began to appear with the words “Just Do It,” and then without any words at all. Apple, McDonald’s, and other brands followed a similar trajectory, gravitating toward entirely textless symbols after a period of transition with logos that had taglines like “Think Different” or “I’m lovin’ it.”
For some Americans, sub-minimum-wage online tasks are the only work available.
Technology has helped rid the American economy of many of the routine, physical, low-paid jobs that characterized the workplace of the last century. Gone are the women who sewed garments for pennies, the men who dug canals by hand, the children who sorted through coal. Today, more and more jobs are done at a computer, designing new products or analyzing data or writing code.
But technology is also enabling a new type of terrible work, in which Americans complete mind-numbing tasks for hours on end, sometimes earning just pennies per job. And for many workers living in parts of the country where other jobs have disappeared—obviated by technology or outsourcing—this work is all that’s available for people with their qualifications.
Saffron has been altering people’s moods for hundreds of years.
It’s the poshest spice of all, often worth its weight in gold. But saffron also has a hidden history as a dye, a luxury self-tanner, and even a serotonin stimulant. That’s right, this episode we’re all about those fragile red threads plucked from the center of a purple crocus flower. Listen in as we visit a secret saffron field to discover why it’s so expensive, talk to a clinical psychologist to explore the science behind saffron’s reputation as the medieval Prozac, and explore the spice’s off-menu role as an all-purpose beautifier for elites from Alexander the Great to Henry VIII.
Saffron’s origins are a mystery, with competing claims placing the wild plant’s origins in regions along a wide, semiarid swath from Greece, in the eastern Mediterranean, to Central Asia. Today, the vast majority is still grown in that belt, with Iran leading the world’s production. But in the 1500s and 1600s, the center of the saffron universe briefly shifted from the sun-baked Mediterranean to rainy England. One particular region of England became so internationally famous for its saffron—in fact, each autumn, the entire area was carpeted in purple petals—that the local market town of Chepying Walden changed its name to Saffron Walden. But by the 1800s, England’s saffron fields had vanished entirely. Two hundred years later, a restless geophysicist named David Smale decided to try cultivating English saffron again. This episode, we visit his field at a secret location in Essex to learn how saffron is grown, hand-harvested, and dried—and about Smale’s uphill battle to uncover the lost art of successfully coaxing saffron from England’s soggy soils.
More comfortable online than out partying, post-Millennials are safer, physically, than adolescents have ever been. But they’re on the brink of a mental-health crisis.
One day last summer, around noon, I called Athena, a 13-year-old who lives in Houston, Texas. She answered her phone—she’s had an iPhone since she was 11—sounding as if she’d just woken up. We chatted about her favorite songs and TV shows, and I asked her what she likes to do with her friends. “We go to the mall,” she said. “Do your parents drop you off?,” I asked, recalling my own middle-school days, in the 1980s, when I’d enjoy a few parent-free hours shopping with my friends. “No—I go with my family,” she replied. “We’ll go with my mom and brothers and walk a little behind them. I just have to tell my mom where we’re going. I have to check in every hour or every 30 minutes.”
Those mall trips are infrequent—about once a month. More often, Athena and her friends spend time together on their phones, unchaperoned. Unlike the teens of my generation, who might have spent an evening tying up the family landline with gossip, they talk on Snapchat, the smartphone app that allows users to send pictures and videos that quickly disappear. They make sure to keep up their Snapstreaks, which show how many days in a row they have Snapchatted with each other. Sometimes they save screenshots of particularly ridiculous pictures of friends. “It’s good blackmail,” Athena said. (Because she’s a minor, I’m not using her real name.) She told me she’d spent most of the summer hanging out alone in her room with her phone. That’s just the way her generation is, she said. “We didn’t have a choice to know any life without iPads or iPhones. I think we like our phones more than we like actual people.”
Stories of gray areas are exactly what more men need to hear.
The story of Aziz Ansari and “Grace” is playing out as a sort of Rorschach test.
One night in the lives of two young people with vintage cameras is crystallizing debate over an entire movement. Depending on how readers were primed to see the ink blot, it can be taken as evidence that the ongoing cultural audit is exactly on track—getting more granular in challenging unhealthy sex-related power dynamics—or that it has gone off the rails, and innocent men are now suffering, and we are collectively on the brink of a sex panic.
Since the story’s publication on Saturday (on the website Babe, without comment from Ansari, and attributed to a single anonymous source), some readers have seen justice in Ansari’s humiliation. Some said they would no longer support his work. They saw in this story yet another case of a man who persisted despite literal and implied cues that sex was not what a woman wanted.Some saw further proof that the problems are systemic, permeating even “normal” encounters.
Allegations against the comedian are proof that women are angry, temporarily powerful—and very, very dangerous.
Sexual mores in the West have changed so rapidly over the past 100 years that by the time you reach 50, intimate accounts of commonplace sexual events of the young seem like science fiction: You understand the vocabulary and the sentence structure, but all of the events take place in outer space. You’re just too old.
This was my experience reading the account of one young woman’s alleged sexual encounter with Aziz Ansari, published by the website Babe this weekend. The world in which it constituted an episode of sexual assault was so far from my own two experiences of near date rape (which took place, respectively, during the Carter and Reagan administrations, roughly between the kidnapping of the Iran hostages and the start of the Falklands War) that I just couldn’t pick up the tune. But, like the recent New Yorker story “Cat Person”—about a soulless and disappointing hookup between two people who mostly knew each other through texts—the account has proved deeply resonant and meaningful to a great number of young women, who have responded in large numbers on social media, saying that it is frighteningly and infuriatingly similar to crushing experiences of their own. It is therefore worth reading and, in its way, is an important contribution to the present conversation.
Like ERs and doctors across the country, administrators at Michigan State assured Nassar’s victims that nothing was wrong.
As a freshman on the Michigan State University softball team, Tiffany Thomas Lopez went to Larry Nassar, the school sports therapist, for back pain. Nassar’s “special treatment”—a technique he’s used on many of his patients, including U.S. Olympic gymnasts—involved him inserting his fingers into her vagina. Thomas Lopez thought something seemed off. But when she reported the behavior to Destiny Teachnor-Hauk, an MSU athletic trainer, she said Teachnor-Hauk told her not to worry: This was “actual medical treatment.”
“She brushed me off, and made it seem like I was crazy,” Thomas Lopez told ESPN.
Last week, almost 100 women shared similar stories about Larry Nassar in a county courtroom in Lansing, Michigan. Many of them were MSU students—and, according to a recent Detroit News investigation, at least six reported the abuse to university administrators. All said they received versions of the same response: “He’s an Olympic doctor.” “No way.” You “must be misunderstanding what was going on.” A 2014 Title IX investigation reached a similar conclusion: Nassar’s conduct “was not of a sexual nature.” Kristine Moore, the university’s Title IX investigator, said the women likely did not understand the “nuanced difference” between proper medical procedure and sexual abuse.